TP53 and acute myeloid leukemia: In addition, the known mutant p53–interacting TFs identified in solid tumor cells or p53R172H/– AML cells were not expressed at significant levels in NPmut HSPCs, nor were the known mutant p53 target genes dysregulated in NPmut HSPCs (20, 81).